 Connection
Hollis Karoly to Cannabinoid Receptor Agonists
This is a "connection" page, showing publications Hollis Karoly has written about Cannabinoid Receptor Agonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.473 |
|
|
|
-
Karoly HC, Prince MA, Emery NN, Smith EE, Piercey CJ, Conner BT. Protocol for a mobile laboratory study of co-administration of cannabis concentrates with a standard alcohol dose in humans. PLoS One. 2022; 17(11):e0277123.
Score: 0.201
-
Karoly HC, Milburn MA, Brooks-Russell A, Brown M, Streufert J, Bryan AD, Lovrich NP, DeJong W, Cinnamon Bidwell L. Effects of High-Potency Cannabis on Psychomotor Performance in Frequent Cannabis Users. Cannabis Cannabinoid Res. 2022 02; 7(1):107-115.
Score: 0.173
-
Martin-Willett R, Skrzynski CJ, Karoly HC, Elmore JS, Bidwell LC. Baseline affective symptomatology moderates acute subjective effects of high potency THC and CBD cannabis concentrates. Exp Clin Psychopharmacol. 2023 Dec; 31(6):1039-1049.
Score: 0.052
-
Bidwell LC, Karoly HC, Torres MO, Master A, Bryan AD, Hutchison KE. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment. Psychopharmacology (Berl). 2022 Feb; 239(2):385-397.
Score: 0.047
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|